Cargando…

Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

Detalles Bibliográficos
Autores principales:	Suzuki, Sho, Ishibashi, Fumiaki, Gotoda, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484766/ https://www.ncbi.nlm.nih.gov/pubmed/36631099 http://dx.doi.org/10.2169/internalmedicine.1282-22

Ejemplares similares

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
por: Sue, Soichiro, et al.
Publicado: (2021)

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
por: Suzuki, Sho, et al.
Publicado: (2020)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
por: Sue, Soichiro, et al.
Publicado: (2017)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
por: Sugimoto, Mitsushige, et al.
Publicado: (2019)

Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori
por: Sue, Soichiro, et al.
Publicado: (2023)

Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Sue, Soichiro, et al.
Publicado: (2018)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2018)

Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?
por: Suzuki, Sho, et al.
Publicado: (2019)

Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Düzenli, Tolga, et al.
Publicado: (2023)

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance
por: Adachi, Kazunori, et al.
Publicado: (2023)

Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2019)

RE: Comment On: Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

The Potential Benefits of Vonoprazan as Helicobacter pylori Infection Therapy
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments
por: Ishibashi, Fumiaki, et al.
Publicado: (2023)

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study
por: Gunaratne, Anoja W, et al.
Publicado: (2021)

Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection
por: Yu, Jing, et al.
Publicado: (2023)

E-Test or Agar Dilution for Metronidazole Susceptibility Testing of Helicobacter pylori: Importance of the Prevalence of Metronidazole Resistance
por: Chen, Jinnan, et al.
Publicado: (2022)

Vonoprazan-Associated Gastric Mucosal Redness in Non-Helicobacter pylori-Infected and Helicobacter pylori-Eradicated Stomach
por: Kubo, Kimitoshi, et al.
Publicado: (2021)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
por: Zhang, Zinan, et al.
Publicado: (2023)

Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication
por: Kusunoki, Maho, et al.
Publicado: (2019)

Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan
por: Howden, Colin W., et al.
Publicado: (2023)

Effect of Temperature on Metronidazole Resistance in Helicobacter pylori
por: Gong, Meiliang, et al.
Publicado: (2021)

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
por: Yamada, Shinya, et al.
Publicado: (2016)

Complete Genome Sequence of a Metronidazole-Resistant Helicobacter pylori Strain
por: Binh, Tran Thanh, et al.
Publicado: (2015)

Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection
por: Lee, Gil Ho, et al.
Publicado: (2020)

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.
por: van der Wouden, E J, et al.
Publicado: (1997)

Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori
por: Hanafi, Aimi, et al.
Publicado: (2016)

The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
por: Choe, Younghee, et al.
Publicado: (2022)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Exploring quality indicators for the detection of Helicobacter pylori-naïve gastric cancer: a cross-sectional nationwide survey
por: Ishibashi, Fumiaki, et al.
Publicado: (2023)

Helicobacter pylori and Pathogenesis
por: Tomoda, Akio, et al.
Publicado: (2015)

RdxA Diversity and Mutations Associated with Metronidazole Resistance of Helicobacter pylori
por: Gong, Yanan, et al.
Publicado: (2023)

Linolenic acid-metronidazole inhibits the growth of Helicobacter pylori through oxidation
por: Zhou, Wen-Ting, et al.
Publicado: (2023)

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
por: Kakiuchi, Toshihiko
Publicado: (2023)

A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori
por: Yang, Faming, et al.
Publicado: (2023)

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
por: Huh, Ki Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hlbhohdhggmocgrg665v22ilhm